Crohn's Disease Clinical Trials

A listing of Crohn's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 318 clinical trials
Featured trial
Crohn's Disease

Crohn's Disease

  • 1219 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Crohn's Study

Crohn's Study  

  • 609 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Crohn's Disease

Crohn's Disease

  • 176 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Crohn's Disease Study

Crohn's Disease Study

  • 270 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Do you suffer from Crohn's Disease?"

Do you suffer from Crohn's Disease?"

  • 146 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Does your stomach pain and diarrhea come from Crohn's disease?

Does your stomach pain and diarrhea come from Crohn's disease?

  • 110 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 2a, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea predominant Irritable Bowel Syndrome (IBS-D)

no history of inflammatory or immune-mediated GI disorders including, but not limited to, inflammatory bowel disease (Crohn’s disease, ulcerative colitis, microscopic colitis, and celiac disease

  • 292 views
  • 20 Aug, 2019
  • 1 location
Featured trial
Active Crohn’s Disease

Active Crohn’s Disease

  • 132 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors

Phase III, Double Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Etrolizumab During Induction and Maintenance in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Refractory to or Intolerant of TNF Inhibitors

  • 184 views
  • 25 Mar, 2021
  • 1 location